Gabriela I. Villanueva

Hematology | Oncology

5721 S Maryland Ave
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Journal: Cancers

Published: February 26, 2026

Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project.

Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project.

Journal: JCO global oncology

Published: December 23, 2025

Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.

Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.

Journal: JCO global oncology

Published: December 23, 2025

Survival in low- and middle-income countries pediatric cancer: encouraging context expertise to inform conclusions in resource-constrained settings.

Survival in low- and middle-income countries pediatric cancer: encouraging context expertise to inform conclusions in resource-constrained settings.

Journal: Journal of the National Cancer Institute

Published: December 09, 2025

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Journal: Cancers

Published: November 26, 2025

Challenges in Launching a Precision Pediatric Oncology Program in Argentina.

Challenges in Launching a Precision Pediatric Oncology Program in Argentina.

Journal: Pediatric blood & cancer

Published: September 08, 2025

Challenges for Early Diagnosis in Retinoblastoma in Low- and Middle-Income Countries.

Challenges for Early Diagnosis in Retinoblastoma in Low- and Middle-Income Countries.

Journal: Pediatric blood & cancer

Published: March 20, 2025

Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.

Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.

Journal: Pediatric blood & cancer

Published: June 06, 2024

Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.

Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.

Journal: Cancer medicine

Published: April 03, 2024

Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.

Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.

Journal: Pediatric hematology and oncology

Published: October 22, 2023

A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma.

A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma.

Journal: Cancers

Published: January 26, 2023

Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic.

Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic.

Journal: Pediatric blood & cancer

Published: January 23, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026